Leonteq Securities’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45 Hold
19
– – ﹤0.01% 1273
2026
Q2
$51 Hold
19
– – ﹤0.01% 1257
2026
Q1
$23 Hold
19
– – ﹤0.01% 1272
2025
Q4
$19 Hold
19
– – ﹤0.01% 1424
2025
Q3
$24 Hold
19
– – ﹤0.01% 1314
2025
Q2
$21 Hold
19
– – ﹤0.01% 1257
2025
Q1
$15 Hold
19
– – ﹤0.01% 1223
2024
Q4
$31 Buy
+19
New +$48 ﹤0.01% 1245
2024
Q3
– Sell
-1,325
Closed -$4.35K – 1229
2024
Q2
$4.35K Hold
1,325
– – ﹤0.01% 1061
2024
Q1
$9.7K Hold
1,325
– – ﹤0.01% 1015
2023
Q4
$4.96K Buy
1,325
+730
+123% +$1.72K ﹤0.01% 1064
2023
Q3
$1.26K Sell
595
-2
-0.3% -$7 ﹤0.01% 1144
2023
Q2
$2.84K Sell
597
-881
-60% -$4.86K ﹤0.01% 1146
2023
Q1
$8.42K Sell
1,478
-12,752
-90% -$76.9K ﹤0.01% 1052
2022
Q4
$144K Buy
14,230
+7,556
+113% +$142K 0.01% 607
2022
Q3
$150K Sell
6,674
-892
-12% -$25.8K 0.01% 579
2022
Q2
$187K Buy
7,566
+2,985
+65% +$82.4K 0.01% 569
2022
Q1
$178K Buy
4,581
+3,538
+339% +$137K 0.01% 616
2021
Q4
$61K Buy
+1,043
New +$59.1K ﹤0.01% 865
2021
Q2
– Sell
-400
Closed -$33K – 1086
2021
Q1
$33K Sell
400
-3,583
-90% -$343K ﹤0.01% 827
2020
Q4
$362K Hold
3,983
– – 0.02% 462

Other funds holding FATE

Leonteq Securities's FATE Position: Q3 2026 in Review

Leonteq Securities held its Fate Therapeutics (FATE) position steady in Q3 2026 at 19 shares worth $45. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Leonteq Securities first reported a position in FATE in Q4 2020 and has held it in 21 quarters since. The position peaked at $362K in Q4 2020. 142 funds tracked by Wall St. Rank hold FATE as of Q3 2026.

  • Leonteq Securities held 19 shares of Fate Therapeutics worth $45 as of Q3 2026.
  • Leonteq Securities left its Fate Therapeutics share count unchanged in Q3 2026.
  • Fate Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1273 holding.
  • Leonteq Securities first reported a position in Fate Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities's Fate Therapeutics position peaked at $362K in Q4 2020.
  • 142 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.